BioSpace News Archive

Iterum Therapeutics plc announced that the Company will release its third quarter 2022 financial results before the open of the U.S. financial markets on Thursday, November 10, 2022.

aTyr Pharma, Inc. announced that it will report third quarter 2022 financial results and provide a corporate update after the market close on Thursday, November 10, 2022.

MiNK Therapeutics, Inc. reported financial results for the third quarter 2022 and provided a corporate update.

CymaBay Therapeutics, Inc. announced that management will participate in the Credit Suisse 31st Healthcare Conference taking place November 7-10, 2022 in Rancho Palos Verdes, CA and the 34th Annual Piper Sandler Healthcare Conference taking place November 29 to December 1, 2022 in New York, NY.

TFF Pharmaceuticals, Inc. announced a collaboration with Aptar Pharma, a global leader in drug delivery and active material science solutions and services, aimed at developing and testing the administration of dry powder vaccines utilizing TFF Pharmaceutical’s Thin Film Freezing technology and Aptar Pharma’s proprietary intranasal Unidose Powder Nasal Spray System.

Aeterna Zentaris Inc. reported its financial and operating results for the third quarter ended September 30, 2022.

Daxor Corporation announces a new study in the prestigious Journal of Cardiac Failure demonstrating the importance and clinical utility of Daxor’s BVA-100 blood test in heart failure.

Mesa Laboratories, Inc. reported results for its second fiscal quarter and six months ended September 30, 2022.

Konica Minolta Healthcare Americas, Inc., a leader in medical diagnostic imaging and healthcare information technology, announces the introduction of new digital radiography solutions that will continue to transform the clinical value of X-ray.

Regulus Therapeutics Inc. today announced that it will report its third quarter 2022 financial results on Thursday, November 10, 2022, after the U.S. financial markets close.